Study on Neuroimaging predictors of Outcome in ECT Patients

Study on Neuroimaging predictors of Outcome in ECT Patients - SNOEP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43040

Enrollment

336

Registered

2016-07-06

Start date

2016-12-19

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolair depression Depression Major depressive disorder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Major depressive disorder (MDD) or depressed bipolar disorder, with or without psychotic symptoms - Clinical indication for ECT - 18 years or older

Exclusion criteria

Exclusion criteria: - Schizophrenia, primary alcohol or drug abuse, or any cognitive disorder

Design outcomes

Primary

Measure	Time frame
Primary Objectives: Our primary objective is to predict antidepressant response to ECT for individual patients using EEG and fMRI data.	—

Secondary

Measure	Time frame
Secondary Objectives: The first secondary objective is to predict cognitive side-effects of ECT for individual patients using EEG and fMRI data. Also, as secondary objective the possible change in EEG and fMRI data directly after a course of ECT and at follow-up will be explored.	—

Countries

Netherlands

Outcome results